epibatidine has been researched along with 2',3'-o-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Collins, AC; Grady, SR; Marks, MJ; McClure-Begley, TD; McIntosh, JM; Wageman, CR; Whiteaker, P | 1 |
1 other study(ies) available for epibatidine and 2',3'-o-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate
Article | Year |
---|---|
A novel α-conotoxin MII-sensitive nicotinic acetylcholine receptor modulates [(3) H]-GABA release in the superficial layers of the mouse superior colliculus.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Acetylcholine; Adenosine Triphosphate; Animals; Bridged Bicyclo Compounds, Heterocyclic; Bungarotoxins; Conotoxins; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; In Vitro Techniques; Iodine Isotopes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotinic Agonists; Nicotinic Antagonists; Protein Binding; Protein Subunits; Pyridines; Receptors, Nicotinic; Serotonin Antagonists; Superior Colliculi; Synaptosomes; Tritium; Tropanes | 2012 |